Triage Survey for Psychiatry Research Eligibility
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed. * Participant is at least 18 years old. Exclusion Criteria: * Participant is pregnant, breast-feeding, or planning to become pregnant. * History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results. * Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening. * Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant. * Any condition that in the investigator's opinion makes a participant unsuitable for the study. * Currently employed by Adams Clinical or a first-degree relative of an employee.
Study sites (6)
MA
- Adams Clinical, Boston · Boston, MA 02116Karla Meehan, MA · Study contact · 617-209-3469 · kmeehan@adamsclinical.comDyanna Domilici, MD · Principal investigatorMore trials in Boston
- Adams Clinical, Watertown · Watertown, MA 02472Miriam Evans, PhD · Study contact · 617-744-8542 · mevans@adamsclinical.comMiriam Evans, PhD · Principal investigatorMore trials in Watertown
NY
- Adams Clinical, Harlem · New York, NY 10029Tessa Candiotti, LCSW · Study contact · 347-238-3704 · tcandiotti@adamsclinical.comWesley Gregory, PHD · Principal investigatorMore trials in New York
- Adams Clinical, Bronx · The Bronx, NY 10461Billye Weiner, LMSW · Study contact · 347-218-9604 · bweiner@adamsclinical.comShama Farooq, MD · Principal investigatorMore trials in The Bronx
PA
- Adams Clinical, Philadelphia · Philadelphia, PA 19104Cassie Blanchard, PHD · Study contact · 617-209-3304 · cblanchard@adamsclinical.comCassie Blanchard, PHD · Principal investigatorMore trials in Philadelphia
TX
- Adams Clinical, Dallas · DeSoto, TX 75115Mink Sandhu, LMSW · Study contact · 945-297-0835 · msandhu@adamsclinical.comRajinder Shiwach, MD · Principal investigatorMore trials in DeSoto